Literature DB >> 24744604

Prolonged small vessel vasculitis with colon mucosal inflammation as first manifestations of Behçet's disease.

Xiao-Ning Yang1, Zhen-Shi Ye1, Yan-Yun Fan1, Yi-Qun Hu1.   

Abstract

Behçet's disease is a chronic, relapsing, systemic vasculitis of unknown aetiology. Patients present manifestations of gastrointestinal complications, including mouth lesions, small and large intestinal lesions, and vascular lesions in the abdomen. In some cases, the intestinal ulcers of patients with Behçet's disease are indistinguishable from those of Crohn's disease, tuberculosis, vasculitis and other diseases. In this article, we present a case of atypical Behçet's disease with a complicated medical history and multisystem damage, for the purpose of better management of this disease.

Entities:  

Keywords:  Behçet’s disease; Intestinal ulcers; Vasculitis

Mesh:

Year:  2014        PMID: 24744604      PMCID: PMC3983471          DOI: 10.3748/wjg.v20.i14.4110

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Behçet's disease.

Authors:  T Sakane; M Takeno; N Suzuki; G Inaba
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Long-term clinical course and prognostic factors in intestinal Behçet's disease.

Authors:  I J Choi; J S Kim; S D Cha; H C Jung; J G Park; I S Song; C Y Kim
Journal:  Dis Colon Rectum       Date:  2000-05       Impact factor: 4.585

3.  Enteroclysis findings of intestinal Behcet disease: a comparative study with Crohn disease.

Authors:  U Korman; M Cantasdemir; S Kurugoglu; I Mihmanli; N Soylu; V Hamuryudan; H Yazici
Journal:  Abdom Imaging       Date:  2003 May-Jun

Review 4.  Adamantiades-Behcet's disease-complicated gastroenteropathy.

Authors:  Qing-Jun Wu; Feng-Chun Zhang; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

5.  Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach.

Authors:  Kenji Kobayashi; Fumiaki Ueno; Seiji Bito; Yasushi Iwao; Tsuneo Fukushima; Nobuo Hiwatashi; Masahiro Igarashi; Bun-Ei Iizuka; Takahide Matsuda; Toshiyuki Matsui; Takayuki Matsumoto; Akira Sugita; Mitsuhiro Takeno; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

6.  EULAR recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-01-31       Impact factor: 19.103

Review 7.  Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-04-17       Impact factor: 19.103

Review 8.  Pathogenic gene responsible for the predisposition of Behçet's disease.

Authors:  N Mizuki; H Inoko; S Ohno
Journal:  Int Rev Immunol       Date:  1997       Impact factor: 5.311

9.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

Authors: 
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-02-26       Impact factor: 6.166

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.